Yuliang Jiang Selected Research

Salvage Therapy

5/2023	Safety and efficacy of CT-guided radioactive iodine-125 seed implantation as a salvage treatment for recurrent head and neck cancer after two or more courses of radiotherapy.
1/2021	Long-Term Safety and Efficacy of CT-Guided I125 Radioactive Seed Implantation as a Salvage Therapy for Recurrent Head and Neck Squamous Carcinoma: A Multicenter Retrospective Study.
1/2020	Efficacy and safety of CT-guided 125I seed implantation as a salvage treatment for locally recurrent head and neck soft tissue sarcoma after surgery and external beam radiotherapy: A 12-year study at a single institution.
1/2019	Efficacy and dosimetry analysis of image-guided radioactive ¹²⁵I seed implantation as salvage treatment for pelvic recurrent cervical cancer after external beam radiotherapy.
1/2016	CT-Guided 125I Seed Interstitial Brachytherapy as a Salvage Treatment for Recurrent Spinal Metastases after External Beam Radiotherapy.
12/2015	Permanent interstitial 125I seed implantation as a salvage therapy for pediatric recurrent or metastatic soft tissue sarcoma after multidisciplinary treatment.
9/2015	CT-guided permanent 125I seed interstitial brachytherapy for recurrent retroperitoneal lymph node metastases after external beam radiotherapy.
12/2014	CT-guidance interstitial (125)Iodine seed brachytherapy as a salvage therapy for recurrent spinal primary tumors.
3/2013	An investigation of 125I seed permanent implantation for recurrent carcinoma in the head and neck after surgery and external beam radiotherapy.
2/2011	Image-guided percutaneous (125)I seed implantation as a salvage treatment for recurrent soft tissue sarcomas after surgery and radiotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuliang Jiang Research Topics

Disease

23	Neoplasms (Cancer) 12/2023 - 02/2011
7	Carcinoma (Carcinomatosis) 10/2022 - 06/2010
5	Head and Neck Neoplasms (Head and Neck Cancer) 05/2023 - 03/2013
5	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 01/2017
4	Sarcoma (Soft Tissue Sarcoma) 01/2023 - 02/2011
4	Lymphatic Metastasis 10/2022 - 09/2015
4	Rectal Neoplasms (Rectal Cancer) 05/2021 - 01/2020
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 01/2019
3	Neoplasm Metastasis (Metastasis) 01/2019 - 01/2016
3	Pain (Aches) 01/2019 - 09/2015
2	Esophageal Squamous Cell Carcinoma 12/2023 - 04/2015
2	Carcinogenesis 01/2018 - 04/2015
2	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 01/2017
2	Glioblastoma (Glioblastoma Multiforme) 11/2017 - 01/2016
2	Pancreatic Neoplasms (Pancreatic Cancer) 12/2013 - 06/2009
1	Esophageal Neoplasms (Esophageal Cancer) 12/2023
1	Adenoid Cystic Carcinoma (Cylindroma) 08/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021
1	Colonic Neoplasms (Colon Cancer) 01/2020
1	Hepatocellular Carcinoma (Hepatoma) 11/2019
1	Pneumococcal Meningitis (Streptococcus pneumoniae Meningitis) 03/2019
1	Inflammation (Inflammations) 03/2019
1	Neuroinflammatory Diseases 03/2019
1	Xerostomia 02/2018
1	Lung Neoplasms (Lung Cancer) 01/2018
1	Hyperhomocysteinemia 01/2016
1	Stomach Neoplasms (Stomach Cancer) 04/2015
1	Wounds and Injuries (Trauma) 04/2015
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 01/2015
1	Spinal Neoplasms 12/2014
1	Exfoliative Dermatitis (Erythroderma) 07/2013

Drug/Important Bio-Agent (IBA)

13	Iodine-125IBA 05/2023 - 06/2009
4	Polysaccharides (Glycans)IBA 01/2020 - 01/2018
3	Tn antigenIBA 01/2019 - 01/2018
2	SurvivinIBA 11/2017 - 01/2016
2	Small Interfering RNA (siRNA)IBA 01/2017 - 04/2015
1	Phospholipases (Phospholipase)IBA 12/2023
1	phospholipase C epsilonIBA 12/2023
1	Therapeutic UsesIBA 12/2022
1	Immune Checkpoint InhibitorsIBA 11/2021
1	Glycoproteins (Glycoprotein)IBA 01/2020
1	TetraspaninsIBA 01/2020
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2020
1	Sorafenib (BAY 43-9006)FDA Link 11/2019
1	Radioisotopes (Radionuclides)IBA 10/2019
1	Phosphatidylinositols (Phosphatidylinositol)IBA 03/2019
1	NF-kappa B (NF-kB)IBA 03/2019
1	diosmetinIBA 03/2019
1	Molecular Chaperones (Chaperone, Molecular)IBA 01/2019
1	MucinsIBA 01/2018
1	NADP TranshydrogenasesIBA 01/2017
1	vasectrin IIIIBA 01/2017
1	RNA IIBA 01/2017
1	Long Noncoding RNAIBA 01/2017
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2016
1	LigandsIBA 01/2016
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	Chemokine CXCL12IBA 01/2016
1	Bone Morphogenetic Protein 2IBA 04/2015
1	IodineIBA 12/2014

Therapy/Procedure

21	Radiotherapy 05/2023 - 02/2011
14	Brachytherapy 09/2023 - 12/2014
10	Salvage Therapy 05/2023 - 02/2011
5	Therapeutics 11/2021 - 06/2010
4	Re-Irradiation 05/2023 - 09/2015
2	Combined Modality Therapy 12/2015 - 04/2015
2	Laparotomy 12/2013 - 06/2009
1	Drug Therapy (Chemotherapy) 05/2023
1	Chemoradiotherapy 11/2021
1	Adjuvant Chemotherapy 11/2021
1	Punctures 08/2021
1	Self Expandable Metallic Stents 01/2021
1	Palliative Care (Palliative Therapy) 01/2018
1	Minimally Invasive Surgical Procedures 01/2018
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2015
1	Retreatment 12/2014
1	Nephrectomy 07/2013
1	Nephrotomy 07/2013